SCHEMBL27915744

SCHEMBL27915744

Cc1ccncc1-n1ncc(-c2ccccc2C(N)=O)c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MAPK14 Q16539 1/20 0.44
RIPK2 O43353 1/20 0.42
LCK P06239 1/20 0.39
BTK Q06187 1/20 0.39
CYP17A1 P05093 2/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NUDT1 P36639 1/20 0.38
LMNA P02545 1/20 0.38
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
SCN9A Q15858 2/20 0.36
SCN5A Q14524 1/20 0.36
CYP1A2 P05177 1/20 0.36
BCAT2 O15382 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
CSNK1A1 P48729 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL627741 0.83 SIRT3 (0.55) SIRT3TDP1MAPK14RIPK2RAB9A
SCHEMBL27715488 0.77 RIPK2 (0.70) MAPK14RIPK2RAB9ASMN1; SMN2LMNA
SCHEMBL1457388 0.73 SIRT3 (0.41) SIRT3TDP1MAPK14RIPK2LCK
SCHEMBL971001 0.72 MAPK14 (0.72) MAPK14RIPK2BTKRAB9ASMN1; SMN2
SCHEMBL30147284 0.72 SIRT3 (0.50) SIRT3TDP1SMN1; SMN2KDM4E
SCHEMBL27717978 0.71 SLC6A9 (0.42) MAPK14RIPK2RAB9ASMN1; SMN2LMNA
SCHEMBL27821329 0.69 SIRT3 (0.57) SIRT3TDP1LCKBTKMKNK1
SCHEMBL6825048 0.69 SIRT3 (0.67) SIRT3TDP1LCKBTKRAB9A
SCHEMBL31554579 0.69 SIRT3 (0.53) SIRT3TDP1RIPK2LCKBTK
SCHEMBL839086 0.66 KMT2A (0.51) MAPK14CYP1A2KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103052639-A 6-cycloalkyl-1, 5-dihydro-pyrazolo [3,4-d ] pyrimidin-4-one derivatives and their use as PDE9A inhibitors BOEHRINGER INGELHEIM INT 2013-04-17 CN disclosed